Skip to content

An exploratory research for biomarker and drug discovery seeds based on glaucoma database[0020]

An exploratory research for biomarker and drug discovery seeds based on glaucoma database[0020] - An exploratory research for biomarker and drug discovery seeds based on glaucoma database

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000021778
Enrollment
3000
Registered
2019-03-31
Start date
2015-01-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

glaucoma

Interventions

None listed

Sponsors

No institute
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Glaucomatous optic change 2) Visual field defects, comfirmed in at least two visula field examinations, for glaucoma. Visual field within the normal limits for preperimetric glaucoma 3) Patients who give written informed consent

Exclusion criteria

Exclusion criteria: 1) Patients who unable to be accepted by doctor 2) Patients who unable to measure intraocular pressure 3) Patients with unable to assess ocular fundus due to corneal or lens opacity 4) Patients with poorly understand the study and unable to give written informed consent.

Design outcomes

Primary

MeasureTime frame
To aggregate analysis using clinical and biological information obtained with our previous research.

Countries

Japan

Contacts

Public ContactYukihiro Shiga

Tohoku University Graduate School of Medicine Department of Ophthalmology

y.shiga@oph.med.tohoku.ac.jp022-717-7294

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026